Exclusive Webinar :Don't miss the latest webinar on Global Investing with Passive Products on June 22, 11am
you are here: HomeNewsBusiness

IndiGo Q4 net loss expands to Rs 1,147 crore amid COVID-19 second wave

The domestic budget carrier's revenue from operations drops 25 percent to Rs 6,222 crore in the March quarter as against Rs 8,299 crore in the corresponding quarter in the previous year.

June 06, 2021 / 07:37 AM IST
Representative image.

Representative image.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Budget carrier Interglobe Aviation Limited (IndiGo) on June 5 announced that it registered a consolidated year-on-year net loss of Rs 1,147 crore in the fourth quarter of FY 2020-21, which ended on March 31, 2021. The airline had posted a loss of Rs 8,70.8 crore in the year-ago period.

Apart from the consolidated loss, the airline's revenue from operations dropped 25 percent to Rs 6,222 crore in the March quarter as against Rs 8,299 crore in the corresponding quarter in the previous year, the company said in a regulatory filing.

COVID-19 fallout | IndiGo reimposes leave without pay policy after decline in passenger traffic

"This has been a very difficult year with our revenues slumping hard due to COVID. After showing some signs of recovery during the December-to-February period, revenues slumped again with the second wave of COVID," IndiGo CEO Ranojoy Dutta said.

Dutta has said that the company has seen a sharp decline in revenues in March through May, and is encouraged by the modest revenue improvements starting last week of May and continuing through June.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"We see this pandemic as a period of great trial for both our shareholders and our employees. We are focusing all our efforts and all our energies to strengthen the foundations and the pillars of IndiGo so that we emerge from this trial significantly stronger structurally and even more customer responsive than ever before. While we have produced disappointing financial results this year, we have also positioned ourselves to be the best-in-class airline when the inevitable recovery finally arrives," Dutta added.

Among other details, IndiGo said that the January to March EBITDAR stands at Rs 648.3 crore with EBITDAR margin of 10.4 percent compared to EBITDAR of Rs 86.7 crore with EBITDAR margin of 1.0 percent for the same period last year (2019-20).

For the full year ended March 2021, the company''s net loss widened to Rs 5,806.4 crore from Rs 233.7 crore in 2019-20 fiscal. Total income fell 58 per cent to Rs 15,677.6 crore in the last financial year. The same stood at Rs 37,291.5 crore in the year-ago period.
Moneycontrol News
first published: Jun 5, 2021 09:24 pm

stay updated

Get Daily News on your Browser
Sections